489(top 1%)
papers
21.7K(top 1%)
citations
75(top 1%)
h-index
140(top 1%)
g-index
601
all documents
25.6K
doc citations
4.1K
citing journals

Top Articles

#TitleJournalYearCitations
1Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences of the United States of America20002,223
2Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelinesClinical Neurophysiology2017847
3Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With NephropathyCirculation2004688
4Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert GuidelinesClinical Neurophysiology2021673
5Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjectsClinical Pharmacology and Therapeutics2001639
6Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced FibrosisAnnals of Internal Medicine2007542
7Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)*1Clinical Pharmacology and Therapeutics1999534
8Prior Statin Therapy Is Associated With a Decreased Rate of Severe SepsisCirculation2004370
9Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure2011355
10Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation studyLancet Diabetes and Endocrinology,the2014329
11Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitisGastroenterology2003310
12The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of MetforminClinical Pharmacology and Therapeutics2009294
13Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 geneClinical Pharmacology and Therapeutics2002279
14Evidence for inverse effects of OATP-C (SLC21A6) *5 and *1b haplotypes on pravastatin kineticsClinical Pharmacology and Therapeutics2004256
15Patient-Tailored Antiemetic Treatment With 5-Hydroxytryptamine Type 3 Receptor Antagonists According to Cytochrome P-450 2D6 GenotypesJournal of Clinical Oncology2002239
16Engineering Myocardial TissueCirculation Research2005238
17Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6Pharmacogenetics and Genomics2003237
18Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical FeaturesCancer Research2012237
19Pharmacokinetics of tacrolimus in liver transplant patients*Clinical Pharmacology and Therapeutics1995219
20Critical Evaluation of the Effect of Valerian Extract on Sleep Structure and Sleep QualityPharmacopsychiatry2000210
21The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ TransplantationClinical Pharmacokinetics2014196
22Toxicity of QuinolonesDrugs1999190
23FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stagesOsteoporosis International2012186
24Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteersClinical Pharmacology and Therapeutics2002185
25Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic DrugsClinical Pharmacokinetics2005181
26Doxazosin in the Treatment of Benign Prostatic Hyperplasia in Normotensive Patients: A Multicenter StudyJournal of Urology1995179
27Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteersPharmacogenetics and Genomics2002175
28The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatmentClinical Pharmacology and Therapeutics2002174
29Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in miceNature Medicine2016172
30Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical managementTransplantation Reviews2015171
31Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trialEuropean Journal of Heart Failure2011161
32Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort studyPLoS Medicine2017161
33Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patientsNephrology Dialysis Transplantation2003159
34Induction of Heat Shock Response Protects the Heart Against Atrial FibrillationCirculation Research2006159
35Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain functionMolecular Psychiatry2013159
36Nonsense-Mediated mRNA Decay and Ubiquitin–Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic MiceCirculation Research2009157
37Decreased Plasma Levels of Amitriptyline and Its Metabolites on Comedication With an Extract From St. John’s Wort (Hypericum perforatum)Journal of Clinical Psychopharmacology2002152
38Variations in the 5-Hydroxytryptamine Type 3B Receptor Gene as Predictors of the Efficacy of Antiemetic Treatment in Cancer PatientsJournal of Clinical Oncology2003147
39Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipientsClinical Pharmacology and Therapeutics1999146
40Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variantsNature Communications2021146
41Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone MethylJournal of Cardiac Failure2014141
42Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational studyAmerican Journal of Transplantation2019141
43An Update on the Therapeutic OrphanPediatrics1999139
44Pharmacokinetic dosing of aminoglycosides: a controlled trialAmerican Journal of Medicine2003138
45Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk FactorsPLoS Genetics2013138
46The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levelsPharmacogenomics Journal2001134
47The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general populationKidney International2005134
48Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetronPharmacogenomics Journal2012133
49Homoarginine Levels Are Regulated by l -Arginine:Glycine Amidinotransferase and Affect Stroke OutcomeCirculation2013132
50Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behaviorNeurology2010130